| 原料品名 | brimonidine tartrate |
|---|---|
| 原料中文名称 | 酒石酸溴莫尼定 |
| 英文别名 | 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-6-quinoxalinamine tartrate |
| 中文别名 | 酒石酸溴莫尼定(标准品);5-溴-6-(咪唑啉-2-基)氨基喹喔啉酒石酸盐;溴莫尼定酒石酸盐;酒石酸溴莫尼定;D-酒石酸溴莫尼定;莫尼定酒石酸盐;溴莫尼定酒石酸盐(CAS号:70359-46-5);酒石酸溴莫尼定:5-溴-6-(咪唑啉-2-基)氨基喹喔啉酒石酸盐 |
| 化学名称 | 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid |
| 分子式 | C11H10N5Br.C4H6O6 |
| 分子量 | 442.22144 |
| CAS号 | 70359-46-5 |
| 结构式图片 | 暂无权限 |
供应商信息
| 企业名称 | Enaltec Labs Pvt Ltd |
|---|---|
| 企业类型 | 生产商 |
| 地址 | 1706,17Th Floor,Kesar Solitaire,Plot No. 5,Sector 19,Sanpada,Navi Mumbai – 400 705,India. |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 公司简介 | Enaltec was established in 2006 by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven products at competitive prices, thus providing the critical India advantage to generic formulators across the world. The paradigm shift of leading Indian pharmaceutical companies to target high volume and blockbuster products for regulated markets has been the inspiration behind the launch of Enaltec. Enaltec is one of the few independent Indian API suppliers with world class infrastructure, having no intention of competing with its customers in their home market. The manufacturing facility at Ambernath is WHO GMP approved and US FDA Inspected and compliant. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
